Ear keloids: An innovative 3‐steps combined treatment

Author:

Domenico Piccolo1,Giuliana Crisman1,Daniele Bollero2,Bruno Bovani3,Alessandro Gennai4,Fabrizio Melfa5,Matteo Tretti Clementoni6,Claudio Conforti7ORCID

Affiliation:

1. Novea Skin Center Avezzano Avezzano L'Aquila Italy

2. Surgery and Aesthetic Plastic Surgeon Torino Italy

3. Surgery and Aesthetic Plastic Surgeon Perugia Italy and Republic of San Marino

4. Studio Gennai Plastic Surgeon Bologna Italy

5. Mediaging Clinic Center Palermo Italy

6. Laserplast Plastic Surgeon Milano Italy

7. Dermatology ClinicIDI‐IRCCS Maggiore Hospital of TriesteDermatological Research Hospital, Rome, Italy Trieste Italy

Abstract

AbstractIntroductionAn excessive proliferation of fibroblasts and collagen synthesis after an injury may lead to a benign fibrous tumor, known as keloid, which does not regress spontaneously. Earlobes are a very frequent site of onset, since after a trauma (i.e., piercing) keloids may develop either on the helix and on the anterior or posterior lobe, from a few months up to several years after the injury.ObjectivesTo report the effectiveness of a combined protocol of CO2 laser + Dye laser + a portable Blue LED Light medical device for Photobiomodulation Therapy (EmoLED®).MethodsFifty‐two patients with a total of 56 ear keloids have been treated in the same session with a single CO2 laser procedure + a pulsed Dye laser procedure with an adjunctive EmoLED® procedure for 3 up to 6 min. A monthly follow‐up has been performed with an adjunctive EmoLED® session in case of signs of inflammation.ResultsAmong 56 treated keloids, 89.3% of them (50/56) did not recur during a follow‐up period (from 6 up to 24 months, mean 16.3 months) while six keloids recurred (6/56, 10.7%) with mild thickening of the scar, thus requiring further treatments.ConclusionsEven if an excellent outcome obtained by the synergistic effect of combined laser treatments has already been described (i.e., CO2 laser + Dye Laser), the present study showed the adjuvant procedure with EmoLED® can reduce significantly the risk of keloids recurrences.

Publisher

Wiley

Subject

Dermatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3